Literature DB >> 25319793

Phage lambda capsids as tunable display nanoparticles.

Jenny R Chang1, Eun-Ho Song, Eri Nakatani-Webster, Lucas Monkkonen, Daniel M Ratner, Carlos E Catalano.   

Abstract

Nanoparticle technologies provide a powerful tool for the development of reagents for use in both therapeutic and diagnostic, or "theragnostic" biomedical applications. Two broad classes of particles are under development, viral and synthetic systems, each with their respective strengths and limitations. Here we adapt the phage lambda system to construct modular "designer" nanoparticles that blend these two approaches. We have constructed a variety of modified "decoration" proteins that allow site-specific modification of the shell with both protein and nonproteinaceous ligands including small molecules, carbohydrates, and synthetic display ligands. We show that the chimeric proteins can be used to simultaneously decorate the shell in a tunable surface density to afford particles that are physically homogeneous and that can be manufactured to display a variety of ligands in a defined composition. These designer nanoparticles set the stage for development of lambda as a theragnostic nanoparticle system.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25319793     DOI: 10.1021/bm5011646

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  8 in total

1.  DNA Packaging and Genomics of the Salmonella 9NA-Like Phages.

Authors:  Chi Zeng; Eddie B Gilcrease; Roger W Hendrix; Yicheng Xie; Michael J Jalfon; Jason J Gill; Sherwood R Casjens
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 2.  Bacteriophage lambda: Early pioneer and still relevant.

Authors:  Sherwood R Casjens; Roger W Hendrix
Journal:  Virology       Date:  2015-03-03       Impact factor: 3.616

Review 3.  Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.

Authors:  Pan Tao; Jingen Zhu; Marthandan Mahalingam; Himanshu Batra; Venigalla B Rao
Journal:  Adv Drug Deliv Rev       Date:  2018-07-06       Impact factor: 15.470

4.  A Designer Nanoparticle Platform for Controlled Intracellular Delivery of Bioactive Macromolecules: Inhibition of Ubiquitin-Specific Protease 7 in Breast Cancer Cells.

Authors:  Wynton D McClary; Alexis Catala; Wei Zhang; Fabia Gamboni; Monika Dzieciatkowska; Sachdev S Sidhu; Angelo D'Alessandro; Carlos E Catalano
Journal:  ACS Chem Biol       Date:  2022-07-07       Impact factor: 4.634

5.  Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.

Authors:  Bennett J Davenport; Alexis Catala; Stuart M Weston; Robert M Johnson; Jeremy Ardanuy; Holly L Hammond; Carly Dillen; Matthew B Frieman; Carlos E Catalano; Thomas E Morrison
Journal:  NPJ Vaccines       Date:  2022-05-26       Impact factor: 9.399

Review 6.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

Review 7.  Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Authors:  Mahdi Karimi; Hamed Mirshekari; Seyed Masoud Moosavi Basri; Sajad Bahrami; Mohsen Moghoofei; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2016-03-17       Impact factor: 15.470

8.  A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague.

Authors:  Pan Tao; Marthandan Mahalingam; Jingen Zhu; Mahtab Moayeri; Jian Sha; William S Lawrence; Stephen H Leppla; Ashok K Chopra; Venigalla B Rao
Journal:  mBio       Date:  2018-10-16       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.